日本PDA学術誌 GMPとバリデーション
Online ISSN : 1881-1728
Print ISSN : 1344-4891
ISSN-L : 1344-4891
解説
ICH Q2(R2),Q14ガイドラインの作成状況と論点解説
檜山 行雄
著者情報
ジャーナル フリー

2020 年 22 巻 2 号 p. 15-21

詳細
抄録

This article describes the drafting process and key points of ICH Q2(R2) (Analytical Validation) and ICH Q14 (Analytical Development). The harmonization effort started in 2018 and the two documents are being drafted by one Expert Working Group. The drafts for public consultation will be published in mid 2021. The revised Q2 will include spectroscopic procedures, procedures used for biologics, multivariate analysis based procedures, etc. The new Q14 will cover Enhanced (Quality by Design) development approach. Q14 emphasizes that the enhanced knowledge supports robust analytical procedures and their effective lifecycle management.

著者関連情報
© 2020 日本PDA製薬学会
feedback
Top